
Protean FusionPlus
Gene fusion testing that identifies specific cancer-driving mutations, including ALK, ROS1, NTRK, and RET.
Protean FusionPlus detects gene fusions that can drive cancer, including ALK, ROS1, NTRK, and RET fusions. It is for patients whose tumors may carry these specific mutations and whose care teams want to find out. Identifying a fusion matters because it names the specific change driving the cancer, giving patients and doctors concrete information to weigh in treatment decisions.
- About 10 business days
- CAP · Accredited laboratory
- CLIA · Certified laboratory
- Pennsylvania DOH · Laboratory permit
- New York State DOH · Laboratory permit
Ask anything about Protean FusionPlus
How Protean FusionPlus works
About 10 business days.
Order the test
The test is ordered through a test requisition form or the ordering portal.
Specimen retrieval
Specimen retrieval and return of FFPE solid tumor tissue is handled by the company.
Receive results
Results are returned in about 10 business days.
Who it's for
Not sure it fits your case? Ask above and get an answer in seconds.
Get started with Protean FusionPlus
What it costs
Accepted
Available
Required
Common questions about Protean FusionPlus
Does Protean FusionPlus take insurance?
Protean FusionPlus accepts insurance; financial assistance is available. Add your plan on OpenCancer to check coverage before you commit.
How do I connect with Protean FusionPlus?
Through OpenCancer's consented intake: enter your details once, choose exactly which records travel with the request, and sign a consent that covers this connection only. Nothing is shared without your sign-off.
Get guidance specific to your case
This page is general information. Add your records and we tailor answers to your diagnosis.